Technology Transfer Office - Case Western Reserve University

The resource for intellectual property management and commercialization at Case Western Reserve University.

We manage intellectual property for all areas of the University and are here to assist CWRU’s faculty, staff and students. This site contains information on our team, policies, and programs, with links to pertinent forms and documents.

SITE MAP:

Welcome to the Case Western Reserve University Technology Transfer Office (TTO) Website. To explore your areas of interest, please select from the list on the left.

Questions?

• For questions about the Drug Discovery and Development Program through access to the University of Cincinnati's High Throughput Screening service, please click here

• For questions about your Invention Disclosure Form (IDF), please contact Joy Chen at 216-368-0362.

• Do you have a Material Transfer Agreement (MTA) that needs to be approved and signed? Please complete our MTA Review Form (required for all MTAs) and send the completed form, along with an electronic copy of the incoming MTA to Anne Di Sante

• For questions about your Material Transfer Agreement (MTA), please contact Anne Di Sante at 216-368-2026.

• For all other questions, please contact Daniel Pendergast at 216-368-0184.

TECHNOLOGY TRANSFER

HIGHLIGHTS

Crain's Cleveland Business: Who To Watch - Joseph Jankowski

Lentigen and UH Case Medical Center Initiate Phase I Trial Using Gene Therapy and Bone Marrow Stem Cells in the Treatment of Brain Cancer

CardioInsight Announces CE Mark Clearance and European Launch of the ECVUE™ Non-Invasive Electrocardiographic Mapping System

Thermalin Diabetes closes $2.85M Series A investment round

CWRU and NeoProteomics Announce Exclusive Option

Isogenic Cell Models for Cancer Research Now Licensed Exclusively to Horizon Discovery in UK

CWRU and Indian Institute of Technology Bombay Establish a Framework to Collaborate

CWRU Technology Transfer Outlook Bright for Research-to-Market Licensing

Ardiem Medical Obtains Non-Exclusive License for Neuromodulation Technology Developed at CWRU and the FES Center

CWRU Grants Option to Startup Thermalin Diabetes Inc.